Free Trial

ANI Pharmaceuticals (ANIP) SEC Filings & 10K Form

ANI Pharmaceuticals logo
$54.21 +0.86 (+1.61%)
(As of 05:26 PM ET)

Recent ANI Pharmaceuticals SEC Filings

DateFilerForm TypeView
12/18/2024
4:59 PM
ANI Pharmaceuticals (Issuer)
CAREY STEPHEN P. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/17/2024
4:35 PM
ANI Pharmaceuticals (Subject)
CAREY STEPHEN P. (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/16/2024
3:20 PM
ANI Pharmaceuticals (Issuer)
Cook Meredith (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/12/2024
4:08 PM
ANI Pharmaceuticals (Issuer)
Davis Krista (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/27/2024
4:38 PM
ANI Pharmaceuticals (Issuer)
Lalwani Nikhil (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/26/2024
6:44 PM
ANI Pharmaceuticals (Subject)
Lalwani Nikhil (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/20/2024
6:00 AM
ANI Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/08/2024
7:01 AM
ANI Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/08/2024
5:55 AM
ANI Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/15/2024
4:57 PM
ANI Pharmaceuticals (Issuer)
Cook Meredith (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/16/2024
3:50 PM
ANI Pharmaceuticals (Issuer)
Cook Meredith (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/16/2024
8:13 AM
ANI Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/13/2024
3:23 PM
ANI Pharmaceuticals (Issuer)
Davis Krista (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/10/2024
3:44 PM
ANI Pharmaceuticals (Issuer)
Lalwani Nikhil (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/14/2024
7:29 AM
ANI Pharmaceuticals (Issuer)
Cook Meredith (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/13/2024
3:21 PM
ANI Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/07/2024
8:51 PM
ANI Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/07/2024
6:26 AM
ANI Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/06/2024
5:53 AM
ANI Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/06/2024
5:57 AM
ANI Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
07/19/2024
4:27 PM
ANI Pharmaceuticals (Issuer)
Cook Meredith (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/19/2024
4:30 PM
ANI Pharmaceuticals (Issuer)
Shanmugam Muthusamy (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/18/2024
4:12 PM
ANI Pharmaceuticals (Subject)
Shanmugam Muthusamy (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
07/17/2024
6:07 PM
ANI Pharmaceuticals (Issuer)
Shanmugam Muthusamy (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/17/2024
3:41 PM
ANI Pharmaceuticals (Subject)
Shanmugam Muthusamy (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
07/16/2024
4:37 PM
ANI Pharmaceuticals (Subject)
Shanmugam Muthusamy (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
07/15/2024
3:57 PM
ANI Pharmaceuticals (Subject)
Shanmugam Muthusamy (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
07/15/2024
3:38 PM
ANI Pharmaceuticals (Issuer)
Cook Meredith (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/02/2024
7:58 PM
ANI Pharmaceuticals (Issuer)
Gassert Chad (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/24/2024
5:56 AM
ANI Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/20/2024
6:11 PM
ANI Pharmaceuticals (Issuer)
Shanmugam Muthusamy (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/20/2024
3:46 PM
ANI Pharmaceuticals (Subject)
Shanmugam Muthusamy (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/18/2024
3:37 PM
ANI Pharmaceuticals (Subject)
Shanmugam Muthusamy (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/14/2024
4:23 PM
ANI Pharmaceuticals (Issuer)
Cook Meredith (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/11/2024
3:51 PM
ANI Pharmaceuticals (Issuer)
Marken James G. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/06/2024
5:21 PM
ANI Pharmaceuticals (Issuer)
Gutwerg Ori (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/06/2024
6:34 AM
ANI Pharmaceuticals (Issuer)
CAREY STEPHEN P. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/05/2024
6:59 AM
ANI Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/04/2024
5:08 PM
ANI Pharmaceuticals (Issuer)
Gassert Chad (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/04/2024
3:35 PM
ANI Pharmaceuticals (Subject)
CAREY STEPHEN P. (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/23/2024
6:54 PM
ANI Pharmaceuticals (Issuer)
Leonard Matthew J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
Crypto’s hidden gem + greatest crypto bull run in history = $$$? (Ad)

You don’t actually want to buy Bitcoin this time around. That’s because there’s a better way to take advantage of this new bull market… One market expert calls it Crypto’s Hidden Gem And it’s a new way that has given folks like you and me the chance to see bigger and faster moves than the traditional way of buying Bitcoin… That means if you’ve stayed away from Bitcoin and crypto because it's confusing or seems risky… This is a much safer and better approach to ride this years’ crypto bull run. Because believe it or not… The 2024 crypto bull run is one you DON’T want to miss.

Click Here to get the full details about Crypto’s Hidden Gem
05/23/2024
6:58 PM
ANI Pharmaceuticals (Issuer)
Pera Antonio R (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/23/2024
6:59 PM
ANI Pharmaceuticals (Issuer)
TANNENBAUM RENEE P (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/23/2024
7:02 PM
ANI Pharmaceuticals (Issuer)
Thoma Jeanne (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/23/2024
7:03 PM
ANI Pharmaceuticals (Issuer)
Walsh Patrick D (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/23/2024
6:45 PM
ANI Pharmaceuticals (Issuer)
HAUGHEY THOMAS (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/22/2024
5:14 PM
ANI Pharmaceuticals (Issuer)
Mutz Christopher (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/21/2024
4:21 PM
ANI Pharmaceuticals (Issuer)
Shanmugam Muthusamy (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/17/2024
5:01 PM
ANI Pharmaceuticals (Issuer)
TANNENBAUM RENEE P (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/17/2024
5:05 PM
ANI Pharmaceuticals (Issuer)
Shanmugam Muthusamy (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/17/2024
3:50 PM
ANI Pharmaceuticals (Subject)
Shanmugam Muthusamy (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/16/2024
4:02 PM
ANI Pharmaceuticals (Issuer)
Lalwani Nikhil (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/16/2024
4:02 PM
ANI Pharmaceuticals (Subject)
TANNENBAUM RENEE P (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/15/2024
3:59 PM
ANI Pharmaceuticals (Subject)
Shanmugam Muthusamy (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/14/2024
6:47 PM
ANI Pharmaceuticals (Subject)
Lalwani Nikhil (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/13/2024
4:25 PM
ANI Pharmaceuticals (Issuer)
Cook Meredith (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/10/2024
6:09 AM
ANI Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/10/2024
5:55 AM
ANI Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/22/2024
5:26 PM
ANI Pharmaceuticals (Issuer)
Shanmugam Muthusamy (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/19/2024
3:43 PM
ANI Pharmaceuticals (Subject)
Shanmugam Muthusamy (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
04/18/2024
3:50 PM
ANI Pharmaceuticals (Subject)
Shanmugam Muthusamy (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
04/17/2024
3:33 PM
ANI Pharmaceuticals (Issuer)
Shanmugam Muthusamy (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/17/2024
3:19 PM
ANI Pharmaceuticals (Subject)
Shanmugam Muthusamy (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
04/17/2024
6:59 AM
ANI Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/16/2024
3:41 PM
ANI Pharmaceuticals (Subject)
Shanmugam Muthusamy (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
04/15/2024
8:33 PM
ANI Pharmaceuticals (Subject)
Shanmugam Muthusamy (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
04/15/2024
5:28 PM
ANI Pharmaceuticals (Issuer)
Cook Meredith (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/11/2024
8:12 PM
ANI Pharmaceuticals (Issuer)
CAREY STEPHEN P. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/11/2024
8:13 PM
ANI Pharmaceuticals (Issuer)
Marken James G. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/08/2024
8:53 PM
ANI Pharmaceuticals (Issuer)
Rowland Thomas Andrew (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
04/05/2024
3:42 PM
ANI Pharmaceuticals (Filer)
Form ARS
04/02/2024
5:59 PM
ANI Pharmaceuticals (Issuer)
Gassert Chad (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/25/2024
3:17 PM
ANI Pharmaceuticals (Issuer)
CAREY STEPHEN P. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/25/2024
3:09 PM
ANI Pharmaceuticals (Issuer)
Lalwani Nikhil (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/14/2024
6:30 AM
ANI Pharmaceuticals (Subject)
Meridian Venture Partners II GP, L.P. (Filed by)
Form SC 13D/A
03/13/2024
3:44 PM
ANI Pharmaceuticals (Issuer)
Gassert Chad (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/13/2024
3:48 PM
ANI Pharmaceuticals (Issuer)
Cook Meredith (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/12/2024
6:07 AM
ANI Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/11/2024
5:58 PM
ANI Pharmaceuticals (Subject)
CAREY STEPHEN P. (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/11/2024
5:39 PM
ANI Pharmaceuticals (Issuer)
CAREY STEPHEN P. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/11/2024
5:43 PM
ANI Pharmaceuticals (Issuer)
Shanmugam Muthusamy (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/08/2024
6:25 PM
ANI Pharmaceuticals (Issuer)
Lalwani Nikhil (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/08/2024
4:59 PM
ANI Pharmaceuticals (Subject)
Lalwani Nikhil (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/07/2024
8:42 PM
ANI Pharmaceuticals (Issuer)
Marken James G. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/07/2024
8:21 PM
ANI Pharmaceuticals (Issuer)
Gutwerg Ori (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/07/2024
8:11 PM
ANI Pharmaceuticals (Issuer)
Shanmugam Muthusamy (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/07/2024
8:16 PM
ANI Pharmaceuticals (Issuer)
Mutz Christopher (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/06/2024
4:58 PM
ANI Pharmaceuticals (Subject)
Lalwani Nikhil (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/06/2024
4:31 PM
ANI Pharmaceuticals (Subject)
Shanmugam Muthusamy (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/06/2024
3:24 PM
ANI Pharmaceuticals (Issuer)
Mutz Christopher (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/06/2024
3:20 PM
ANI Pharmaceuticals (Issuer)
Pera Antonio R (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
Crypto’s hidden gem + greatest crypto bull run in history = $$$? (Ad)

You don’t actually want to buy Bitcoin this time around. That’s because there’s a better way to take advantage of this new bull market… One market expert calls it Crypto’s Hidden Gem And it’s a new way that has given folks like you and me the chance to see bigger and faster moves than the traditional way of buying Bitcoin… That means if you’ve stayed away from Bitcoin and crypto because it's confusing or seems risky… This is a much safer and better approach to ride this years’ crypto bull run. Because believe it or not… The 2024 crypto bull run is one you DON’T want to miss.

Click Here to get the full details about Crypto’s Hidden Gem
03/04/2024
6:18 PM
ANI Pharmaceuticals (Subject)
Pera Antonio R (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/01/2024
4:09 PM
ANI Pharmaceuticals (Issuer)
Marken James G. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/01/2024
4:12 PM
ANI Pharmaceuticals (Issuer)
Mutz Christopher (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/01/2024
4:18 PM
ANI Pharmaceuticals (Issuer)
Shanmugam Muthusamy (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/01/2024
3:55 PM
ANI Pharmaceuticals (Issuer)
CAREY STEPHEN P. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/29/2024
6:22 AM
ANI Pharmaceuticals (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
02/29/2024
5:58 AM
ANI Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/23/2024
3:51 PM
ANI Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/16/2024
3:47 PM
ANI Pharmaceuticals (Issuer)
Marken James G. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:ANIP) was last updated on 12/23/2024 by MarketBeat.com Staff
From Our Partners